InMode Ltd. Ordinary Shares
Symbol: INMD (NASDAQ)
Company Description:
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
- Today's Open: $15.05
- Today's High: $15.293
- Today's Low: $14.91
- Today's Volume: 76.23K
- Yesterday Close: $15.02
- Yesterday High: $15.4835
- Yesterday Low: $14.8604
- Yesterday Volume: 1.24M
- Last Min Volume: 253
- Last Min High: $15.154
- Last Min Low: $15.14
- Last Min VWAP: $15.14356
- Name: InMode Ltd. Ordinary Shares
- Website: https://www.inmodemd.com
- Listed Date: 2019-08-08
- Location: ,
- Market Status: Active
- CIK Number: 0001742692
- SIC Code:
- SIC description:
- Market Cap: $949.40M
- Round Lot: 100
- Outstanding Shares: 63.21M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-07-30 | 6-K | View |
2025-07-17 | SCHEDULE 13G/A | View |
2025-05-19 | 6-K | View |
2025-04-28 | 6-K | View |
2025-04-03 | 6-K | View |
2025-03-13 | CORRESP | View |
2025-03-13 | SCHEDULE 13D/A | View |
2025-03-11 | CORRESP | View |
2025-03-06 | UPLOAD | View |
2025-02-06 | 6-K/A | View |
2025-02-04 | S-8 | View |
2025-02-04 | 20-F | View |
2025-02-04 | 6-K | View |
2025-01-16 | SCHEDULE 13D | View |
2024-10-30 | 6-K | View |
2024-10-16 | UPLOAD | View |
2024-10-11 | CORRESP | View |
2024-10-01 | 6-K | View |
2024-09-30 | UPLOAD | View |
2024-09-23 | CORRESP | View |